Validation of PROMIS Banks With COPD Exacerbations

Inclusion Criteria:

• An established clinical history of COPD in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) definition: COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases.
• A history of smoking (at least 10 pack/year history)
• Access to and able to communicate on a touch tone telephone
• Read and speak English
• Able to see and interact with a computer screen, mouse, and keyboard
• A signed and dated written informed consent prior to study participation
• For those enrolled into the exacerbation group: Treatment for an exacerbation may have been started no more than 3 days prior to the day of enrollment for patients recruited in the outpatient setting and no more than 6 days prior to the day of enrollment for patients recruited in the in-patients setting.
• For those enrolled in the stable state group, the patient will be considered stable if he or she has been exacerbation-free for a minimum of 2 months prior to enrollment.

Exclusion Criteria:

• Any concurrent medical or psychiatric condition that may preclude participation in this study or completion of self-administered questionnaires (e.g., moderate to severe dementia and/or severe, uncontrolled schizophrenia, or other condition that would render the participant unable to complete a questionnaire)
• History of asthma without co-existent COPD as the primary diagnosis
• Experiencing a current heart failure exacerbation. (A diagnosis of heart failure is not in itself an exclusion criterion.)